Leslie Newman, PhD
Assistant Professor - Practice
141D Parks Hall
Professional Interests
Biography
Leslie C Newman, PhD, is an Assistant Professor in the Division of Pharmacy Education and Innovation at The Ohio State University College of Pharmacy. She received her Master’s in Pharmacology from Louisiana State University Medical School and her Doctorate in Biomedical Sciences from Oklahoma State University Center for Health Sciences. Dr. Newman also completed postdoctoral training in Pharmacogenomics at The Ohio State University Wexner Medical Center.
Dr. Newman’s teaching responsibilities in the Bachelor of Science in Pharmaceutical Sciences (BSPS) program include teaching in and directing the first of a two-course sequence, Molecules to Medicines I: an Integrated Approach to the Pharmaceutical Sciences. Dr. Newman has also developed and expanded courses dealing with drug use in American culture, substance use disorder, and pharmacogenomics which are offered university-wide through the General Education (GE) program.
Dr. Newman’s teaching responsibilities in the Doctor of Pharmacy program involve teaching in the Integrated Pharmacotherapy (IP) course sequence and serving as the science coordinator for IP3. She also developed a graduate elective, Neurobiology of Addiction, for the Doctor of Pharmacy program which is also available to graduate students outside of the college of pharmacy.
Outside of the classroom, Dr. Newman has served as a Second-year Transformational Experience Program (STEP) mentor since 2018. She is also involved in projects to evaluate how various active learning strategies contribute to enhanced student engagement, learning, and creativity. She is specifically studying the effects of how a better understanding of the neurobiology of substance use disorder contributes to alleviating the stigma that is prevalent in society and in the health care field.
Education
- 2010-2014, Post-Doctoral Fellow, The Ohio State University Wexner Medical Center
- 2000, PhD, Biomedical Sciences, Oklahoma State University Center for Health Sciences
- 1995, MS, Pharmacology, Louisiana State University Medical Center
Honors
- 2023 Award For Distinguished Teaching In Pharmaceutical Sciences, The Ohio State University
- 2019 Award For Distinguished Teaching In Pharmaceutical Sciences, The Ohio State University
- 2000 Graduate Research Excellence Award, Oklahoma State University
- 1999 1st Place Presentation Award, Oklahoma Society of Physiology
- 1999 Endowed Graduate Fellowship, Oklahoma State University
Publications
- RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles., BMC genomics. 2015 Nov | journal-article. doi: 10.1186/s12864-015-2207-8.
- Genetic variants affecting alternative splicing of human cholesteryl ester transfer protein., Biochemical and biophysical research communications. 2014 Jan | journal-article. doi: 10.1016/j.bbrc.2013.12.127.
- Whole transcriptome RNA-Seq allelic expression in human brain., BMC genomics. 2013 Aug | journal-article. doi: 10.1186/1471-2164-14-571.
- Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk., PloS one. 2012 Mar | journal-article. doi: 10.1371/journal.pone.0031930.
- Distinct cellular pools of perilipin 5 point to roles in lipid trafficking., Biochimica et biophysica acta. 2011 Oct | journal-article. doi: 10.1016/j.bbalip.2011.10.017.
- Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates., The Journal of pharmacology and experimental therapeutics. 2002 Apr | journal-article. doi: 10.1124/jpet.301.1.364.
- Testing and comparison of non-opioid analgesics in amphibians., Contemporary topics in laboratory animal science. 2001 Jul | journal-article. .
- Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord., Brain research. 2000 Nov | journal-article. doi: 10.1016/s0006-8993(00)02967-x.
- Selective opioid receptor agonist and antagonist displacement of [3H]naloxone binding in amphibian brain., European journal of pharmacology. 2000 Jun | journal-article. doi: 10.1016/s0014-2999(00)00265-x.
- Characterization of [3H]-diprenorphine binding in Rana pipiens: observations of filter binding enhanced by naltrexone., Journal of pharmacological and toxicological methods. 1999 Feb | journal-article. doi: 10.1016/s1056-8719(99)00020-9.
- Spinal administration of selective opioid antagonists in amphibians: evidence for an opioid unireceptor., Life sciences. 1999 Jan | journal-article. doi: 10.1016/s0024-3205(99)00013-2.
- Detection of low affinity interactions between peptides and heat shock proteins by chemiluminescence of enhanced avidity reactions (CLEAR)., Nature biotechnology. 1996 Mar | journal-article. doi: 10.1038/nbt0396-348.